-

BOC/BOA 2024 | Dr. Qiang Liu: China’s Breast Cancer Research at the Forefront of the World, ctDNA-Guided Precision Treatment Development Trend
From July 5-7, 2024, the “2024 Annual Progress in Clinical Oncology Conference (BOC) and Best of ASCO® 2024 China (BOC/BOA)” was grandly held in Guangzhou. In the field of breast cancer, this conference highlighted key advancements from the American Society of Clinical Oncology (ASCO) annual meeting, showcasing China’s research impact on the international stage. “Oncology…
-

Applying Integrated Medicine in Breast Cancer Prevention and Treatment | Dr. Jiong Wu, 2024 CACA Conference
On July 12-13, the 2024 CACA Integrated Breast Cancer Conference was held in Kunming, hosted by the Chinese Anti-Cancer Association (CACA) and the CACA Integrated Breast Cancer Committee, and organized by the China Academy of Integrated Medicine and Strategy Development, Yunnan Cancer Hospital, and ten professional committees. “Oncology Frontier” invited Dr. Jiong Wu, Chairman of…
-

Advancing Comprehensive Breast Cancer Care: Prevention, Screening, Diagnosis, Treatment, and Rehabilitation | Dr. Jin Zhang, 2024 CACA Conference
The “2024 CACA Integrated Breast Cancer Conference,” hosted by the Chinese Anti-Cancer Association and the Chinese Anti-Cancer Association’s Breast Cancer Committee, was held in Kunming, Yunnan, from July 12-13, 2024. The conference, under the theme “Cancer Prevention and Treatment: Winning Through Integration,” focused on new concepts, knowledge, and technologies in breast cancer diagnosis and treatment,…
-

Cardiac Safety Management in Antitumor Therapy: Current Challenges and Future Development of Cardio-Oncology | Dr. Fengqi Fang, 2024 CACA Conference
With the continuous advancement of cancer treatment technologies, the survival rate of cancer patients has significantly improved, but the issue of cardiac safety during antitumor therapy has increasingly become a clinical focus. In this context, cardio-oncology has emerged as an important interdisciplinary field. At the “2024 CACA Integrated Breast Cancer Conference,” during the breast cancer…
-

Dr. Songqing Ye: Analysis of 2024 ASCO Breast Cancer ADC Research Progress
At the 2024 ASCO Conference, the progress in breast cancer ADC (antibody-drug conjugate) research was remarkable. T-DXd demonstrated excellent efficacy in HER2-positive breast cancer, significantly extending patient survival and reinforcing the concept of using the best drugs first. In HR-positive and triple-negative breast cancer, Dato-DXd showed good safety and efficacy, laying the foundation for future…
-

Dr. Litao Zhang Interprets Wuhan Asia General Hospital’s Innovative Anticoagulation Research
From June 22 to June 26, 2024, the 32nd International Society on Thrombosis and Haemostasis (ISTH 2024) conference was successfully held in Bangkok, Thailand. At this prestigious event, the research achievements of Dr. Litao Zhang’s team from Wuhan Asia General Hospital shone brightly. Several studies on anticoagulation management were selected, showcasing their significant contributions and…
-

BOC/BOA 2024 | Dr. Ye Guo Shares Advances in Head and Neck Tumor Research and Benefits of Personalized Treatment
Head and neck tumors are common malignant tumors among Chinese residents, significantly impacting organ function, quality of life, and prognosis due to disease progression and treatment effects. The “2024 Annual Progress in Clinical Oncology Conference (BOC) and Best of ASCO 2024 China” was recently held in Guangzhou, showcasing the progress of clinical oncology research in…
-

The visit of Dr. Tao Cheng, President of the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
From July 11 to 12, Dr. Tao Cheng, President of the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS), and his delegation visited Thailand. They met with representatives from the Ministry of Public Health of Thailand, the Embassy of The People’s Republic of China in the Kingdom of Thailand ,…